Health TrialsbyHealthPanel

Enhanced Recovery After Surgery in Hysterectomy Patients

ConditionEnhanced Recovery After Surgery (ERAS) Protocol
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorCairo University

About this trial

This prospective randomized controlled clinical trial aims to evaluate the effectiveness of Enhanced Recovery After Surgery (ERAS) protocols in patients undergoing elective hysterectomy. ERAS is an evidence-based perioperative approach designed to reduce surgical stress, accelerate recovery, and improve clinical outcomes. Participants will be randomized to receive either ERAS-based care or conventional perioperative management. The study will assess whether ERAS implementation reduces hospital stay and improves postoperative recovery without increasing complications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women aged 18-70 years.

Undergoing elective total hysterectomy for benign or early stage malignant gynacological conditions .

ASA ( American Society of Anesthesiologists ) physical status I-II.

Able to provide informed consent.

Disqualifiers

Emergency hysterectomy

Advanced malignant requiring extensive debulking

Known bowel disease or previous bowel surgery ( crohn's disease , bowel obstruction )

Significant cognitive impairment or psychiatric illness

Trial design

Design model

Parallel

Treatments tested in this trial

  • dextrose (5%)

    Drug

    IV dextrose infusion (5%) 500 ml once ,2-3 hours before anesthesia

  • ERAS protocols

    Procedure/Surgery

    Reduced fasting Early oral feeding Early mobilization

Treatment groups

78 Participants
are divided into 2 treatment groups
Group A: ERAS groupActive comparator 2 interventions
Group B: Conventional careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

length of hospital stay (LOS)

Time from completion of surgery to hospital discharge readiness, measured in days.

Time frame
From day of surgery up to 7 postoperative days

Secondary outcomes

1

postoperative pain score

Postoperative pain intensity measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain).

Time frame
At 12 and 24 hours postoperatively
2

time to first bowel movement

the interval (in hours) from completion of surgery to the first documented passage of stool."

Time frame
Up to 5 postoperative days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: